Market Cap 8.43B
Revenue (ttm) 3.12B
Net Income (ttm) 322.95M
EPS (ttm) N/A
PE Ratio 5.20
Forward PE 5.34
Profit Margin 10.36%
Debt to Equity Ratio 0.65
Volume 1,484,500
Avg Vol 3,108,976
Day's Range N/A - N/A
Shares Out 172.83M
Stochastic %K 83%
Beta 1.32
Analysts Sell
Price Target $58.75

Company Profile

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle...

Industry: REIT - Office
Sector: Real Estate
Phone: 626 578 0777
Fax: 626 578 0896
Website: www.are.com
Address:
26 North Euclid Avenue, Pasadena, United States
Rumplenickledime
Rumplenickledime Dec. 27 at 4:23 PM
$ARE who is considering a buy for the dividend?
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 27 at 2:09 AM
$ARE chopping this company to pieces and selling it off while else scratching their name from every corner post until thy name is never spoken again is a more likely outcome.🤣
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 27 at 1:10 AM
$ARE recovery in real estate takes years not weeks.
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 27 at 1:08 AM
$ARE 54-56? I don’t think so. The blood bath will likely continue. At best you are looking at your 3 dollar trading range now.
1 · Reply
Monsters_of_Swing
Monsters_of_Swing Dec. 26 at 4:40 PM
$ARE first target zone for January $54-$56
1 · Reply
MansasAlgo
MansasAlgo Dec. 26 at 4:36 PM
$ARE S&P projected that occupancy could drop into the high-80% range in 2026 due to known tenant move-outs in the life sciences sector. ​Analysts are also projecting a high-single-digit decline in same-property cash NOI for 2026.
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Dec. 26 at 4:24 PM
$ARE net asset value $97 per share
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Dec. 26 at 4:21 PM
$ARE just lay back and relax let shorties play preparing for 2026
0 · Reply
MansasAlgo
MansasAlgo Dec. 26 at 4:20 PM
$ARE strong short activity isn't surprising. Of the last buyback announcement of up to 500 million, only just over half of that was bought back. Shorts will be betting this is more a verbal support for the stock rather than an establishment of a floor. If the company actually had the "excess" cash to buy back $500 million in stock, would they have needed to desert their income-focused shareholders by nearly halving the dividend? With the possibility of vacancies rising further and securities class action lawsuits ongoing the bear case is still very strong. There needs to be a positive suprise Jan's ER regarding tenancies for this to finally find it's bottom
0 · Reply
Daniel3303
Daniel3303 Dec. 26 at 3:56 PM
$ARE Almost 2/3 of recent activity is short selling
0 · Reply
Latest News on ARE
REIT Dividend Traps To Avoid In 2026

Dec 20, 2025, 8:50 AM EST - 7 days ago

REIT Dividend Traps To Avoid In 2026

ADC BXP GNL GOOD HST NNN O


The 5 Cheapest Large Cap REITs For 2026

Dec 18, 2025, 9:45 AM EST - 9 days ago

The 5 Cheapest Large Cap REITs For 2026

AMT AVB CCI DLR EQIX EQR ESS


REIT Bulls - Brace For More Frustration

Dec 5, 2025, 9:15 AM EST - 22 days ago

REIT Bulls - Brace For More Frustration

AHH EPR EPRT NNN O SPY STAG


The State Of REITs: November 2025 Edition

Nov 18, 2025, 12:33 PM EST - 5 weeks ago

The State Of REITs: November 2025 Edition

AHR BBRE BDN CCI DFAR DHC FREL


Winners And Losers Of REIT Earnings Season

Nov 14, 2025, 8:00 AM EST - 6 weeks ago

Winners And Losers Of REIT Earnings Season

ABR ACRE AGG AGNC AGNCM AHR ALEX


Alexandria Real Estate: Buy The Fear Or Steer Clear?

Nov 11, 2025, 4:06 PM EST - 6 weeks ago

Alexandria Real Estate: Buy The Fear Or Steer Clear?


When The Stimulus Stops

Nov 9, 2025, 9:00 AM EST - 6 weeks ago

When The Stimulus Stops

AGG AGNC AGNCM AGNCN AGNCO AGNCP AMH


Alexandria Real Estate: I'm Buying The Post-Earnings Plunge

Nov 8, 2025, 11:32 PM EST - 6 weeks ago

Alexandria Real Estate: I'm Buying The Post-Earnings Plunge


Watch These Stocks Falling 10% Or More

Nov 4, 2025, 4:58 PM EST - 7 weeks ago

Watch These Stocks Falling 10% Or More

AJG BAX BRO CAVA CMG DECK ERIE


Rumplenickledime
Rumplenickledime Dec. 27 at 4:23 PM
$ARE who is considering a buy for the dividend?
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 27 at 2:09 AM
$ARE chopping this company to pieces and selling it off while else scratching their name from every corner post until thy name is never spoken again is a more likely outcome.🤣
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 27 at 1:10 AM
$ARE recovery in real estate takes years not weeks.
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 27 at 1:08 AM
$ARE 54-56? I don’t think so. The blood bath will likely continue. At best you are looking at your 3 dollar trading range now.
1 · Reply
Monsters_of_Swing
Monsters_of_Swing Dec. 26 at 4:40 PM
$ARE first target zone for January $54-$56
1 · Reply
MansasAlgo
MansasAlgo Dec. 26 at 4:36 PM
$ARE S&P projected that occupancy could drop into the high-80% range in 2026 due to known tenant move-outs in the life sciences sector. ​Analysts are also projecting a high-single-digit decline in same-property cash NOI for 2026.
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Dec. 26 at 4:24 PM
$ARE net asset value $97 per share
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Dec. 26 at 4:21 PM
$ARE just lay back and relax let shorties play preparing for 2026
0 · Reply
MansasAlgo
MansasAlgo Dec. 26 at 4:20 PM
$ARE strong short activity isn't surprising. Of the last buyback announcement of up to 500 million, only just over half of that was bought back. Shorts will be betting this is more a verbal support for the stock rather than an establishment of a floor. If the company actually had the "excess" cash to buy back $500 million in stock, would they have needed to desert their income-focused shareholders by nearly halving the dividend? With the possibility of vacancies rising further and securities class action lawsuits ongoing the bear case is still very strong. There needs to be a positive suprise Jan's ER regarding tenancies for this to finally find it's bottom
0 · Reply
Daniel3303
Daniel3303 Dec. 26 at 3:56 PM
$ARE Almost 2/3 of recent activity is short selling
0 · Reply
Daniel3303
Daniel3303 Dec. 26 at 3:51 PM
$ARE A lot of short selling going on here which makes no sense since the company is buying back 500M$ in shares.
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:33 PM
$ARE Actionable Trade Alert: Market Context: $ARE is currently trading at $48.76, positioned between its 60-day high of $85.37 and low of $44.10. The RSI of 59.68 indicates bullish momentum, suggesting potential for upward movement. Directional Bias: The stock is trading below the 30-day moving average (MA30) of $49.37 and significantly below the 50-day moving average (MA50) of $55.78, indicating a potential reversal or upward correction. The current price is near the lower end of its recent range, which supports a bullish outlook. Trade Plan: - Suggested Entry: $48.76 - Stop Loss: $46.00 (approximately 5.7% risk) - Take Profit Targets: 1. $52.00 (6.5% ROI) 2. $56.00 (14.8% ROI) 3. $57.00 (17% ROI) This plan allows for a strategic entry with defined risk and multiple profit-taking opportunities. Monitor price action closely for confirmation. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 12:17 PM
$ARE RSI: 59.68, MACD: -1.9874 Vol: 2.89, MA20: 48.39, MA50: 55.78 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
sceptre_sights
sceptre_sights Dec. 24 at 5:33 PM
$ARE ARE investors can check out $XBI as a leading indicator of some demand for biotech which is a positive sign for ARE clients, future activity and life sciences tenants. Of course 2026 guide was very tough but mgmt ripped the band aid off to be positioned appropriately.
1 · Reply
Bazzzigar
Bazzzigar Dec. 24 at 1:42 PM
$ARE with rate cut it should be above $60
1 · Reply
MansasAlgo
MansasAlgo Dec. 23 at 12:56 PM
$ARE dump into ex date last day of this year ?
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Dec. 22 at 1:33 PM
$ARE book value per share $97.70 a big thanks to all short-sellers and to all tax-loss sellers
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 22 at 12:36 PM
$ARE may crater again
0 · Reply
MansasAlgo
MansasAlgo Dec. 22 at 10:03 AM
$ARE institutions selling into the buyback last Friday? Big volume
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 19 at 7:38 PM
$ARE glad I dumped this for a small profit. Watching.
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Dec. 19 at 4:49 PM
$ARE has sentiment ever been this negative? most can't see it now, but better times ahead
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:27 PM
Actionable Trade Alert for $ARE: Market Context: $ARE is currently trading at $48.95, showing a bearish trend with the RSI at 36.35, indicating it is nearing oversold conditions. The price is below both the 30-day MA of 50.44 and the 50-day MA of 58.43, reinforcing a downward bias. The 60-day high of 86.74 and low of 44.1 suggests a significant range, providing potential for a rebound. Directional Bias: Given the current RSI and the proximity to the 60-day low, a bullish reversal is possible, especially if the price approaches the lower end of this range. Trade Plan: - Suggested Entry: $48.95 - Stop Loss: $44.10 (60D Low) - Take Profit Targets: 1. $54.00 (Target 1, approx. 10% ROI) 2. $60.00 (Target 2, approx. 22% ROI) 3. $57.50 (Target 3, approx. 17% ROI) This plan leverages the potential for a bounce back from the low range while managing risk effectively. https://privateprofiteers.com
0 · Reply